Delivery Order SPE2DB25D3020-SPE2DB25FWJBD

Award Date 6/17/25
Potential Completion Date 7/10/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,118.08 firm fixed-price contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to provide a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $8,061.38 and runs through January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,123.96, is for the delivery of 4,568,143,236 units of the prescription medication IBRANCE 75 MG CAPSULE 21S. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. The contract has an ultimate completion date of May 27, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $7,792.08 and is a firm-fixed price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $16,236.16 and a period of performance through June 4, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a $16,247.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The order is for the medication IBRANCE 75 MG CAPSULE 21S, and has a period of performance through July 1, 2025. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $8,067.35, and has an ultimate completion date of January 17, 2025. The contract covers the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $77,920.80 and is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The contract is a Firm Fixed Price type and has an ultimate completion date of August 21, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ibrance 75 mg capsules, a brand-name pharmaceutical product. The contract has a firm fixed price of $8,123.96 and a period of performance ending on May 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $7,797.84 firm-fixed-price contract is for the delivery of IBRANCE 75 MG CAPSULE 21S, a prescription medication. The contract has a completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWJBD
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of IBRANCE 125 MG CAPSULE 21S medication. The $8,118.08 firm fixed-price contract has a completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely one of multiple orders under that larger IDC contract, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military and federal healthcare programs.

Generated 9/16/25, 9:54 AM